Announced Mon, 25 May · 19:58 IST

Yatharth Hospital & Trauma Care Services Limited has informed the Exchange about Investor Presentation

Promoter Disclosed Acquisition PlansAnalyst Day Multiyear TargetsMgmt Guided Margin ImprovementInvestor Communications View source PDF

YATHARTH · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-0.1%1-day move
₹816.00
prior close
₹828.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.4+0.1+1.3+1.0-0.1-3.2-3.2-0.2-0.7-0.7+0.8+3.7+3.6
Up moveDown movePending
AI summary

Yatharth Hospital reported strong Q4 FY26 results with revenue of Rs 3,416 million (up 47% YoY) and PAT of Rs 447 million (up 15% YoY). For full year FY26, revenue grew 36% to Rs 12,072 million with PAT of Rs 1,703 million (up 30%). The hospital chain expanded bed capacity to 2,800+ beds with occupancy improving to 71% and ARPOB at Rs 33,283. Cash generation was exceptional with operating cash flow of Rs 2,866 million (up 82% YoY) and cash conversion ratio at 98% versus 70% last year. New hospitals in Delhi, Faridabad Sec-20, and Agra are ramping up well, contributing 22% of Q4 revenues. The company acquired a 250-bed under-construction hospital in Gurugram for Rs 100 crore, expected to be operational by April 2027.

Likely market impact

Strong operational growth and improved cash generation are positives for shareholders. The adjusted EBITDA margin of 28.5% (excluding new hospital ramp-up costs) indicates solid underlying profitability. The expansion roadmap targeting 5,000 beds over 3 years signals continued growth but may require significant capital deployment.